• Prometheus Bio is ready for its close-up shot, following a $130M round to back IBD drugs now headed to the clinic

    19 days ago - By San Diego Biotechnology

    A little over a year ago, Takeda lined up a deal to collaborate with a low-profile San Diego upstart called Prometheus Biosciences on a string of new drugs for inflammatory bowel disease. The pharma player tossed an undisclosed upfront and up to $420 m......
    Read more ...